TY - JOUR
T1 - A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice
AU - Drel, Viktor R.
AU - Pacher, Pal
AU - Vareniuk, Igor
AU - Pavlov, Ivan
AU - Ilnytska, Olga
AU - Lyzogubov, Valeriy V.
AU - Tibrewala, Jyoti
AU - Groves, John Taylor
AU - Obrosova, Irina G.
N1 - Funding Information:
This study was supported by the American Diabetes Association Research Grant 7-05-RA-102, the Juvenile Diabetes Research Foundation International Grant 1-2005-223, the National Institutes of Health Grant DK 071566-01 (all to I.G.O.), and the Intramural Research Program of the National Institutes of Health/National Institute of Alcohol Abuse and Alcoholism (to P.P.). Metalloporphyrin synthesis was supported by the National Institutes of Health Grant GM 36298 and the New Jersey Commission on Science and Technology (both to JTG). The authors thank Nazar Mashtalir and Jeho Shin for expert technical assistance.
PY - 2007/8/13
Y1 - 2007/8/13
N2 - Whereas an important role of free radicals and oxidants in peripheral diabetic neuropathy is well established, the contribution of nitrosative stress and, in particular, of the highly reactive oxidant peroxynitrite, has not been properly explored. Our previous findings implicate peroxynitrite in diabetes-associated motor and sensory nerve conduction deficits and peripheral nerve energy deficiency and poly(ADP-ribose) polymerase activation associated with Type 1 diabetes. In this study the role of nitrosative stress in diabetic sensory neuropathy is evaluated. The peroxynitrite decomposition catalyst Fe(III) tetrakis-2-(N-triethylene glycol monomethyl ether)pyridyl porphyrin (FP15) was administered to control and streptozotocin (STZ)-diabetic mice at the dose of 5 mg kg- 1 day- 1 (FP15), for 3 weeks after initial 3 weeks without treatment. Mice with 6-week duration of diabetes developed clearly manifest thermal hypoalgesia (paw withdrawal, tail-flick, and hot plate tests), mechanical hypoalgesia (tail pressure Randall-Sellito test), tactile allodynia (flexible von Frey filament test), and ∼ 38% loss of intraepidermal nerve fibers. They also had increased nitrotyrosine and poly(ADP-ribose) immunofluorescence in the sciatic nerve, grey matter of spinal cord, and dorsal root ganglion neurons. FP15 treatment was associated with alleviation of thermal and mechanical hypoalgesia. Tactile response threshold tended to increase in response to peroxynitrite decomposition catalyst treatment, but still remained ∼ 59% lower compared with non-diabetic controls. Intraepidermal nerve fiber density was 25% higher in FP15-treated than in untreated diabetic rats, but the difference between two groups did not achieve statistical significance (p = 0.054). Nitrotyrosine and poly(ADP-ribose) immunofluorescence in sciatic nerve, spinal cord, and dorsal root ganglion neurons of peroxynitrite decomposition catalyst-treated diabetic mice were markedly reduced. In conclusion, nitrosative stress plays an important role in sensory neuropathy associated with Type 1 diabetes. The findings provide rationale for further studies of peroxynitrite decomposition catalysts in a long-term diabetic model.
AB - Whereas an important role of free radicals and oxidants in peripheral diabetic neuropathy is well established, the contribution of nitrosative stress and, in particular, of the highly reactive oxidant peroxynitrite, has not been properly explored. Our previous findings implicate peroxynitrite in diabetes-associated motor and sensory nerve conduction deficits and peripheral nerve energy deficiency and poly(ADP-ribose) polymerase activation associated with Type 1 diabetes. In this study the role of nitrosative stress in diabetic sensory neuropathy is evaluated. The peroxynitrite decomposition catalyst Fe(III) tetrakis-2-(N-triethylene glycol monomethyl ether)pyridyl porphyrin (FP15) was administered to control and streptozotocin (STZ)-diabetic mice at the dose of 5 mg kg- 1 day- 1 (FP15), for 3 weeks after initial 3 weeks without treatment. Mice with 6-week duration of diabetes developed clearly manifest thermal hypoalgesia (paw withdrawal, tail-flick, and hot plate tests), mechanical hypoalgesia (tail pressure Randall-Sellito test), tactile allodynia (flexible von Frey filament test), and ∼ 38% loss of intraepidermal nerve fibers. They also had increased nitrotyrosine and poly(ADP-ribose) immunofluorescence in the sciatic nerve, grey matter of spinal cord, and dorsal root ganglion neurons. FP15 treatment was associated with alleviation of thermal and mechanical hypoalgesia. Tactile response threshold tended to increase in response to peroxynitrite decomposition catalyst treatment, but still remained ∼ 59% lower compared with non-diabetic controls. Intraepidermal nerve fiber density was 25% higher in FP15-treated than in untreated diabetic rats, but the difference between two groups did not achieve statistical significance (p = 0.054). Nitrotyrosine and poly(ADP-ribose) immunofluorescence in sciatic nerve, spinal cord, and dorsal root ganglion neurons of peroxynitrite decomposition catalyst-treated diabetic mice were markedly reduced. In conclusion, nitrosative stress plays an important role in sensory neuropathy associated with Type 1 diabetes. The findings provide rationale for further studies of peroxynitrite decomposition catalysts in a long-term diabetic model.
KW - Intraepidermal nerve fiber loss
KW - Nitrosative stress
KW - Peroxynitrite decomposition catalyst
KW - Poly(ADP-ribose) polymerase
KW - Tactile allodynia
KW - Thermal hypoalgesia
UR - http://www.scopus.com/inward/record.url?scp=34547398616&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547398616&partnerID=8YFLogxK
U2 - 10.1016/j.ejphar.2007.05.055
DO - 10.1016/j.ejphar.2007.05.055
M3 - Article
C2 - 17644085
AN - SCOPUS:34547398616
SN - 0014-2999
VL - 569
SP - 48
EP - 58
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1-2
ER -